This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. rose 5.7% to $7.76 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 19,215.46 and the Dow Jones Industrial Average rising 0.3% to 42,792.07.
This was the stock's third consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 87.5% short of its 52-week high of $61.90, which the company reached on July 31st.
The stock outperformed some of its competitors, as Vanda Pharmaceuticals Inc. rose 3.6% to $4.31, Fortress Biotech Inc. fell 2.8% to $1.76, and Viking Therapeutics Inc. fell 3.27% to $27.50.
Trading volume totaled 197,038, compared to the 50-day average of 178,161.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 19, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.